Table 1.
Study (year) | Study type | Study quality | Patients | Average age (years old) | Follow-up time | Surgical level |
---|---|---|---|---|---|---|
Abudurexiti T (2018) [13] | Prospective cohort study | NOS 8 stars | 82/134 | 38.2±9.2/ 36.3±8.6 | 6 months to 2 years | L2–S1 (mostly L4/L5, L5/S1) |
Chen Z (2018) [14] | RCT | CONSORT 20/22 items | 80/73 | 40.2±11.4/ 40.7±11.1 | 1 year | L3–S1 (mostly L4/L5, L5/S1) |
Liu T (2012) [15] | Retrospective cohort study | NOS 6 stars | 25/13 | 41.5 (21–67) | 13.5 months | L2–S1 (mostly L4/L5, L5/S1) |
Li H (2018) [16] | Case-control study | NOS 8 stars | 48/30 | 19.0±2.0/ 19.4±1.5 | 5 years | L3–S1 (mostly L4/L5, L5/S1) |
Liu X (2017) [17] | Retrospective cohort study | NOS 7 stars | 60/63 | 36.2±5.9/ 33.1±6.7 | 2 years | L3–L5 (mostly L4/L5) |
Song H (2017) [18] | Case-control study | NOS 8 stars | 30/30 | 54.8±6.5/ 53.6±6.4 | 18 months | T12–S1 |
Sinkemani A (2015) [19] | Case-control study | NOS 7 stars | 36/50 | 44.2±6.5/ 41.5±7.2 | 1 year | L3–S1 (mostly L4/L5, L5/S1) |
Yoon S (2012) [20] | Retrospective cohort study | NOS 6 stars | 25/26 | 45.9 (13–70)/ 56.5 (32–79) | 6 months at least | L1–S1 (mostly L4/L5, L5/S1) |
RCT – randomized controlled trial; NOS – Newcastle-Ottawa Scale; CONSORT – Consolidated Standards of Reporting Trials.